Use of tocilizumab in COVID-19 pneumonia hospitalized patients. Cohort study

INTRODUCTION: In COVID 19, an aggressive inflammatory response called cytokine release storm has been described. It is mainly mediated by the activation of Interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α), mainly observed in critically ill patients. Among the multiple treatments proposed...

Descripción completa

Detalles Bibliográficos
Autores principales: Anci, Cynthia, Solavallone, Vanina, Cardone, Romina, Orlando, Juan Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Colombiana de Medicina Crítica y Cuidado lntensivo. Published by Elsevier España, S.L.U. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671622/
http://dx.doi.org/10.1016/j.acci.2022.10.004

Ejemplares similares

Ejemplares similares